Progesterone and luteal blood flow effects of an i.u. 2-h infusion of 0.25 mg/h of prostaglandin F 2a (PGF) that simulated a natural pulse of 13,14-dihydro-15-keto-PGF (PGFM) were compared to the effects of a single bolus i.u. injection of PGF (4 mg) that induced complete luteolysis in heifers. Blood sampling and an estimate of the percentage of luteal area with colour-Doppler signals of blood flow were performed every 2 min for 20 min and less frequently thereafter for 6 h. After the beginning of PGF infusion or a bolus injection, progesterone increased to a peak at 14 and 10 min respectively, and was accompanied by an increase in blood flow in the bolus group but not in the infusion group. Progesterone then decreased for 1 or 2 h and was accompanied by a continued elevation in blood flow in the PGF bolus group and by a slight increase in the PGF infusion group. Progesterone then rebounded in both groups, but the rebound was greater in the infusion group. Blood flow decreased during the descending arm of the progesterone rebound. Cortisol and prolactin began to increase 6 min after the bolus PGF injection but did not increase during or after PGF infusion. The increases in cortisol, prolactin and blood flow after a PGF bolus treatment but not during a simulated PGFM pulse indicated that the bolus treatment was pharmacologic, and its use may lead to faulty conclusions on the nature of physiologic luteolysis. The comparisons between progesterone and blood flow are novel.
Introduction
During luteolysis in cattle, prostaglandin F 2a (PGF) is secreted from the uterus in pulses, based on the assay of the PGF metabolite 13,14-dihydro-15-keto-PGF (PGFM; Kindahl et al. 1976 , Mann & Lamming 2006 . Several PGFM pulses may occur each day, and each pulse is several hours in duration. A dose of PGF or a PGF analogue that induces complete luteolysis with a single treatment causes an immediate transient increase in progesterone prior to the decrease (Lamond et al. 1973 , Hixon & Hansel 1974 , Skarzynski et al. 2003 . The transient increase is reportedly a non-physiologic response to a pharmacologic dose of PGF in heifers (Ginther et al. 2009a , Shrestha et al. 2010 and mares (Ginther et al. 2007a (Ginther et al. , 2009c . In a study with a limited number of heifers per group, an initial transient increase in progesterone occurred 10 min after a single bolus i.u. luteolytic dose of PGF, but an increase that appeared to occur by 20 min after the beginning of i.u. infusion to simulate a PGFM pulse was not significant (Shrestha et al. 2010) .
A colour-Doppler ultrasonographic study in cattle has indicated that treatment with a single luteolytic dose of a PGF analogue increased luteal blood flow between treatment and 30 min (first posttreatment examination) in temporal association with a decrease in progesterone (Acosta et al. 2002) . These findings have been confirmed using systemic and i.u. routes of PGF treatment in various doses (Ginther et al. 2007b (Ginther et al. , 2009b . In addition, based on either 12-or 24-h intervals between examinations (Miyamoto et al. 2005 , Shirasuna et al. 2008 , the progesterone decrease associated with spontaneous luteolysis was reported to be preceded by increased blood flow to the corpus luteum (CL). It has therefore been postulated that an increase in luteal blood flow is an initial event in the PGF-induced luteolytic cascade ). The temporal relationship between the immediate (within 10 min) transient progesterone increase and luteal blood flow after a pharmacologic dose of PGF is unknown. Furthermore, an immediate increase in progesterone during a simulated PGFM pulse has not been adequately investigated, owing to the limited number of heifers (nZ4/group) in the only available report (Shrestha et al. 2010) .
After the transient increase from a single bolus treatment with PGF or a PGF analogue that induces complete luteolysis, a decrease in progesterone occurs for about 1 h and may be followed by a cessation of the decrease or a transient rebound during the next few hours before continuing the decrease (Hixon & Hansel 1974 , Stellflug et al. 1977 , Schallenberger et al. 1984 , Baishya et al. 1994 . A single dose of PGF that induces only partial luteolysis apparently does not induce an immediate transient increase, but is associated with a more prominent transient rebound than for a dose that induces complete luteolysis (Ginther et al. 2009a) . The transient rebound in progesterone is distinguishable from the immediate posttreatment transient increase by a decrease in progesterone before the rebound (Fig. 1) . In addition, a pronounced transient progesterone rebound began at 1 h during a 2-h i.u. infusion of PGF to simulate a PGFM pulse (Shrestha et al. 2010) ; the progesterone decrease after the rebound was followed by progesterone resurgence, so that the interval to ovulation was not shortened by the single simulated pulse. The relationship of the progesterone rebound with the changes in luteal blood flow has not been determined.
A bolus luteolytic dose of PGF (e.g. 25 mg, systemically) or a PGF analogue in cattle stimulates increased concentrations of LH within 3.5 h and prolactin and cortisol within 1 h after treatment (Louis et al. 1974 , Tucker et al. 1975 , Stellflug et al. 1977 , Renegar et al. 1978 , Furr et al. 1981 , Schams & Karg 1982 , Schallenberger et al. 1984 , Baishya et al. 1994 . It is unknown whether these hormone responses to a single luteolytic dose of PGF represent physiologic or pharmacologic responses. An incorrect assumption that the responses are physiologic could lead to dubious experimental interpretations regarding the mechanism of spontaneous luteolysis. In this regard in mares, progesterone, FSH and LH increased immediately after a bolus luteolytic dose of PGF (Ginther et al. 2007a (Ginther et al. , 2009c , but not during the simulation of a PGFM pulse (Ginther et al. 2009c ).
Three hypotheses were tested in heifers in the present experiment: 1) a transient increase in progesterone occurs during infusion of PGF to simulate a natural PGFM pulse, which is based on a reported increase that did not reach significance but with a limited number of heifers (Shrestha et al. 2010) ; 2) the luteal blood flow increase after a single luteolytic dose of PGF accompanies the progesterone decrease, which is based on a rationale from Acosta et al. (2002) and 3) the immediate response of circulating hormones, other than progesterone, to a single completely luteolytic dose of PGF does not occur during a simulated pulse of PGFM, which is based on a rationale primarily from a study in mares (Ginther et al. 2009c ). In addition, we determined the temporal relationships between changes in progesterone concentrations and changes in luteal blood flow during and until 4 h after a 2-h simulated PGFM pulse. The changes in progesterone and luteal blood flow were examined every 2 min for 20 min during the expected immediate progesterone increase to determine if one end point preceded the other. Determinations were made less frequently during the expected progesterone rebound.
Results
When the group-by-minute/hour interaction is significant, the probability for a difference among minutes or hours within each group and end point is shown in the figures. When the minute/hour effect is significant for a group, significant changes (increases and decreases) within the group are also indicated for progesterone and blood flow.
For PGFM concentrations during Minutes 0-60 (Fig. 2) , the main effects of group and minute and the interaction of group and minute were each significant (P!0.0001). The interaction represented differences among groups for the following significant changes within groups: saline infusion group -no differences; PGF infusion group -increased by Minute 6, continued to increase until Minute 30 and did not change between Minutes 30 and 60; saline bolus group -no differences; and PGF bolus group -increased by Minute 2 and decreased between Minutes 10 and 60. The greater PGFM concentration in the PGF bolus group than in the PGF infusion group continued until the last examination (Minute 60).
For progesterone concentrations during Minutes 0-60 (Fig. 3) , the minute effect and the interaction were significant (P!0.0001). The interaction represented differences among groups for the following significant changes within groups: saline infusion group -no differences; PGF infusion group -increased between Minutes 0 and 10, decreased between Minutes 14 and 30 and continued to decrease until Minute 60; saline bolus group -increased between Minutes 0 and 8, decreased between Minutes 8 and 14, increased between Minutes 14 and 20 and decreased between Minutes 20 and 60; and PGF bolus group -increased between Minutes 0 and 4, decreased between Minutes 10 and 14 and continued to decrease until Minute 60. The difference in progesterone concentrations between Minute 0 and the maximum concentration was less (approached significance; P!0.1) in the PGF infusion group (1.1G0.3 ng/ml) than in the PGF bolus group (1.9G0.5 ng/ml). The interval from Minute 0 to the maximum concentration was greater (P!0.02) in the PGF infusion group (16.7G1.8 min) than in the PGF bolus group (12.2G1.0 min). The area under the curve for Minutes 0-25 was greater (P!0.05) in the PGF bolus group (3.4G0.2 ng/min per ml) than in the saline bolus group (2.0G0.2 ng/min per ml). The difference in progesterone concentration between maximum and Minute 60 was less (P!0.007) in the PGF infusion group (2.8G0.3 ng/ml) than in the PGF bolus group (4.4G0.5 ng/ml).
For progesterone concentrations during Hours 0-6 (Fig. 3) , the main effects of group (P!0.03) and hour (P!0.0001) and the interaction (P!0.0001) were significant. The interaction represented differences among groups for the following significant changes within groups: saline infusion group -decreased between Hours 0 and 2.5, increased between Hours 2.5 and 3.25 and continued to increase until Hour 5; PGF infusion group -decreased between Hours 0 and 1, increased between Hours 2 and 2.75, decreased between Hours 3.25 and 3.75 and continued to decrease until Hour 5; saline bolus group -no differences until Hour 3.5 and then concentrations increased (approached significance; P!0.07); and PGF bolus group -decreased between Hours 0 and 1, increased between Hours 1 and 2.75, decreased between Hours 2.75 and 4 and continued to decrease until Hour 6. The area under the curve for progesterone concentrations during the rebound was greater (P!0.05) for Hours 2-5 in the PGF infusion group (0.72G0.10 ng/h per ml) than for Hours 1-4 in the PGF bolus group (0.42G0.04 ng/h per ml). The difference in percentage decrease in progesterone from Hours 0-6 approached significance (P!0.09) between the PGF infusion group (30.4 G19.1%) and the PGF bolus group (59.4G3.9%).
The length of the interval from the pretreatment to posttreatment ovulations was different (P!0.0001) among groups. The intervals were as follows: saline infusion group, 20.9 For the percentage of CL area with colour-Doppler signals of blood flow during Minutes 0-60 (Fig. 3) , the minute effect (P!0.02) and the interaction (P!0.0004) were significant. The interaction represented differences among groups for the following significant changes within groups: saline infusion group -no differences; PGF infusion group -no differences; saline bolus groupincreased between Minutes 0 and 16 and decreased between Minutes 16 and 45; and PGF bolus groupincreased between Minutes 0 and 10 and continued to increase until Minute 60. For the percentage of CL area with colour-Doppler signals of blood flow during Hours 0-6, the group effect (P!0.001), hour effect (P!0.0001) and the interaction (P!0.0001) were significant (Fig. 3) . The interaction represented differences among groups for the following significant changes within groups: saline infusion group -decreased (approached significance; P!0.06) after Hour 0; PGF infusion group -increased between Hours 0 and 2, decreased between Hours 2 and 4 and continued to decrease until Hour 6; saline bolus group -decreased between Hours 2.5 and 4; and PGF bolus group -increased between Hours 0 and 1, decreased between Hours 2 and 2.75 and continued to decrease until Hour 6. For cortisol concentrations during Minutes 0-60 (Fig. 4) , the minute effect (P!0.0004) and the interaction (P!0.0001) were significant. The interaction represented a decrease over Minutes 0-60 in the saline infusion, PGF infusion and saline bolus groups versus an increase between Minutes 6 and 30 in the PGF bolus group. The cortisol concentration was greater (P!0.005) at each examination from Minutes 14-60 in the PGF bolus group than in each of the other groups. For prolactin concentration during Minutes 0-60 (Fig. 4) , the main effects and the interaction were each significant (P!0.0001). The interaction represented changes that were similar among groups as for the cortisol concentrations. For Hours 0-6, only the interaction was significant (P!0.009), representing primarily no differences in the saline infusion, PGF infusion and saline bolus groups and an increase between Hours 0 and 1 followed by a decrease until Hour 6 in the PGF bolus group (not shown). For oestradiol concentrations during Minutes 0-60, only the minute effect was significant (P!0.01; not shown); concentrations were low (range of means, 0.1-0.5 pg/ml).
There were no significant differences for FSH concentrations during Minutes 0-60 (Fig. 5 ). During Hours 0-6, the FSH concentrations were significant for hour (P!0.0001) and for the interaction (P!0.006). The interaction represented no change in the two saline groups and a greater increase over Hours 0-6 in the PGF infusion group than in the PGF bolus group. Concentrations of LH showed only a minute effect (P!0.008), owing primarily to a decrease (P!0.05) between Minutes 0 and 25 averaged over groups (Fig. 5 ). During Hours 0-6, LH concentrations showed significance for each main effect (P!0.0001) and for the interaction (P!0.002). The interaction represented no differences in the two saline groups versus a similar increase in the PGF infusion and PGF bolus groups during Hours 1-6. Concentrations of LH in the PGF bolus group increased (P!0.02) between Hours 1 and 2.25 during the ascending arm of the progesterone rebound, continued to increase until a decrease (P!0.004) between Hours 3.25 and 3.75 during the descending arm of the progesterone rebound, and then increased (P!0.02) until the end of the experiment at Hour 6. 
Discussion
The interval from the first manipulation of the cervix and uterus until the start of PGF treatment and the quantity of fluid inserted i.u. were different between the infusion and the bolus groups. However, the differences do not appear to have compromised the testing of the three hypotheses or comparisons between the two infusion groups or between the two bolus groups, including study of the concomitant relationships between changes in luteal blood flow and circulating progesterone concentration. A change in PGFM concentrations was not detected in the saline infusion or saline bolus group. The apparent (non-significant) immediate increase in the means for the saline bolus group was primarily from one heifer. The present protocol precluded determining whether organ manipulation stimulated the secretion of PGF in the infusion groups before the collection of blood samples. In this regard, secretion of PGF was not detected in cattle during cervical and uterine manipulation on days 2-8 of the oestrous cycle (Manns & Newcomb 1975) or during transrectal palpation of the reproductive tract and direct massage of the cervix 12 days after oestrous (Alam & Dobson 1986) .
Hypothesis 1 was supported by the immediate transient increase in progesterone in association with an individual simulated pulse of PGFM in the PGF infusion group. Whether a similar transient progesterone increase occurs during the initial portion of a spontaneous PGFM pulse is unknown. At the time of the first significant increase in progesterone at Minute 10, only 0.04 mg of PGF had been infused, indicating a sensitive positive progesterone response to a minimal increase in PGF exposure.
A greater immediate progesterone increase in the PGF bolus group than in the PGF infusion group was indicated by the tendency for a greater difference in progesterone concentration between Minute 0 and maximum and the shorter interval between Minute 0 and maximum, and may have been related to greater PGFM concentration in the PGF bolus group. The reason for the immediate positive progesterone response to PGF treatment is not known. Based on an in vitro study (Speroff & Ramwell 1970) , a direct PGF steroidogenic stimulation of luteal cells has been suggested (Hixon & Hansel 1974) . Direct inhibitory and stimulating effects of PGF on small and large luteal cells respectively have been demonstrated in vitro (Alila et al. 1988 , Meidan et al. 1992 , Girsh et al. 1995 , Okuda et al. 1998 , Skarzynski & Okuda 1999 . In addition, the results of studies involving treatment with a bolus luteolytic dose of PGF have been interpreted to indicate that nitric oxide is a crucial factor in initiating luteolysis through a drastic increase in luteal blood flow (Shirasuna et al. 2008) , and that the induced increase in luteal blood flow is the first step in the luteolytic cascade (Miyamoto et al. 2005 ). However, a direct functional role of the acute increase in luteal blood flow in the ensuing luteolysis has not been demonstrated. In the present study, the use of frequent examinations (intervals of 2 min between Minutes 0 and 20) showed that blood flow and progesterone increased concomitantly between Minutes 0 and 10 in the PGF bolus group. Thus, Hypothesis 2 that a luteal blood flow increase after a single luteolytic dose of PGF accompanies the progesterone decrease during the first hour was not supported, but would have been supported if the first posttreatment examination had been done at Minute 30 as reported by Acosta et al. (2002) . The increase in luteal Figure 4 MeanGS.E.M. for circulating concentrations of cortisol (nZ5) and prolactin (nZ9) from a 2-h i.u. infusion of saline or prostaglandin F 2a (PGF, 0.5 mg) or bolus i.u. injection of saline or PGF (4 mg). The interaction of group and minute was significant for each end point. The probabilities for a minute effect for each group are shown.
Luteal blood flow and progesterone production blood flow during the immediate transient progesterone increase in the PGF bolus group may have involved a direct effect of the excessive dose of PGF, and the blood flow increase may have contributed to the immediate transient progesterone increase. PGF is known to have haemodynamic effects in many organs including the CL (Fortier et al. 2008) .
The factors involved in the immediate increase in luteal blood flow in the saline bolus group are unknown. Manipulation of the reproductive organs may have stimulated vasoactive factors or a neural response. The increase in progesterone concentrations in the saline bolus group is compatible with the assumption that an increase in luteal blood flow can stimulate increased progesterone production. The increased blood flow along with the moderate increase in progesterone in the saline bolus group is the best indicator within this experiment that increased luteal blood flow alone can increase progesterone output. The greater area of progesterone under the curve in the PGF bolus group than in the saline bolus group seems to indicate that both PGF and increased luteal blood flow may have contributed to the increased progesterone production. In the PGF infusion group, a blood flow increase was not detected during the immediate transient progesterone increase, but it could have occurred during the w20 min between the beginning of organ manipulation and Minute 0. When all data were considered between Minutes 0 and 60, there was no significant time effect on blood flow.
The decrease in progesterone after the immediate transient increase continued until the beginning of the rebound at Hour 1 in the PGF bolus group and at Hour 2 in the PGF infusion group. The rebound is consistent with previous reports (see Introduction), including the more prominent rebound in association with the simulated PGFM pulse than with the PGF bolus treatment (Shrestha et al. 2010) . The descending arm of the rebound extended until the end of the experiment (Hour 6) in the PGF bolus group, but the decline ended at Figure 5 MeanGS.E.M. for circulating concentrations of FSH and LH from a 2-h i.u. infusion of saline or prostaglandin F 2a (PGF, 0.5 mg) or bolus i.u. injection of saline or PGF (4 mg; nZ9 and 5 heifers/group for Minutes 0-60 and Hours 0-6 respectively). For FSH, there were no significant effects during Minutes 0-60 and an interaction for Hours 0-6. For LH, there was only a main effect of minutes for Minutes 0-60 and an interaction for Hours 0-6. The probabilities for a time effect within each end point and group are shown.
Hour 5 in the PGF infusion group at a concentration similar to the concentration at the onset of the rebound. Resurgence in progesterone has been reported to occur after the descending arm of the progesterone rebound from the simulation of a PGFM pulse (Ginther et al. 2009a , Shrestha et al. 2010 . Resurgence likely occurred in the present experiment as indicated by the cessation of the progesterone decrease at Hour 5 and an interovulatory interval that was similar to the interval in the controls.
An increase in luteal blood flow during the hours of an expected or demonstrated progesterone rebound has been reported for exogenous PGF using several doses, routes and methods of administration (Ginther et al. 2007b (Ginther et al. , 2009b . In the present experiment, the elevated luteal blood flow during the progesterone rebound after Hour 1 in the PGF bolus group seemed to represent primarily a continuation of the blood flow increase that occurred concomitantly with the immediate posttreatment increase in progesterone. In the PGF infusion group, a slight but significant increase in blood flow occurred between Hours 0 and 2 concomitant with the decrease in progesterone between the peak of the immediate transient increase and the beginning of the rebound. Thus, in both PGF-treated groups, blood flow remained elevated or increased slightly during the time that progesterone was decreasing before the onset of the rebound. Blood flow decreased approximately during the descending arm of the progesterone rebound in both PGF-treated groups. During spontaneous luteolysis, luteal blood flow increases during the 3-h ascending arm of a PGFM pulse, reaches maximum at the peak of the pulse and remains elevated for 2 h before decreasing (Ginther et al. 2007b) . The blood flow changes associated with the progesterone rebound in the PGF infusion group seem to be consistent with the reported spontaneous results. Blood flow remained elevated for about 2 h after the end of PGF infusion and similarly for 2 h after a spontaneous PGFM peak.
The acute increase in both cortisol and prolactin, beginning at Minute 6 after the injection of a luteolytic dose of PGF, is consistent with the literature. In cattle, an acute increase in cortisol and prolactin occurred after a luteolytic dose of PGF or PGF analogue (Louis et al. 1974 , Furr et al 1981 , Baishya et al. 1994 . PGs are signal transducers in neurohormone regulatory functions (Bugajski et al. 2004 ). In addition, PGs directly stimulate steroidogenesis of bovine adrenocortical cells (Wang et al. 2000) . The gradual decrease in cortisol and prolactin during the 60 min after treatment or the beginning of infusion in the saline and PGF infusion groups and in the saline bolus group may represent a gradual recovery from animal handling. This cannot be substantiated from the present study, owing to unavailability of blood samples before Minute 0. However, cortisol is released rapidly when cattle are exposed to stress or an environmental disturbance, and the release ends rapidly when the stressor ceases (Hopster et al. 1999 , Ferin 2006 . A short release of prolactin also occurs during stress (Raud et al. 1971) and during rectal massage of the cervix and vagina in cattle (Karg & Schams 1974) . A neuroendocrine regulatory system involving the hypothalamic-pituitary area and the adrenocortical system are used for adaptation to environmental changes (Ferin 2006) .
During Minutes 0-60, concentrations of FSH were not altered in any group, whereas LH showed only a slight effect of minute averaged over groups. Over Hours 1-6, both PGF infusion and a PGF bolus stimulated an increase in both FSH and LH without a response to saline infusion or injection. The increase in LH after a luteolytic dose of PGF or a PGF analogue in a previous study occurred at a similar time as in the present study, but an FSH increase was not detected (Baishya et al. 1994) . In contrast to heifers, a luteolytic dose of PGF in mares causes an immediate (within 5 min) increase in both gonadotrophins, and the elevated concentrations continue for 2 h (Ginther et al. 2007a ).
Hypothesis 3 was tested by assay of the concentrations of cortisol, prolactin, FSH and LH to determine if immediate responses of these hormones occur after a bolus PGF luteolytic injection but do not occur during a simulated PGFM pulse. The FSH and LH responses were not useful for testing the hypothesis. However, the immediate increase in cortisol and prolactin in the PGF bolus group but not in the saline bolus group indicated that the responses were attributable to the excessive dose of PGF and not to stress associated with the heifer handling or manipulation of the reproductive organs. The profound difference between a PGF bolus dose that induced complete luteolysis and an infusion dose that simulates a natural PGFM pulse in the cortisol and prolactin responses supported Hypothesis 3. The different progesterone and luteal blood flow responses between an excessive PGF dose and a dose that simulates a PGFM pulse further supported this conclusion. Therefore, caution should be exercised in developing postulates on the nature of the luteolytic mechanism when based on unnatural PGF doses, unnatural routes of PGF administration or unnatural forms of PGF (analogues).
In conclusion, an immediate transient posttreatment increase in progesterone was more prominent after a bolus luteolytic i.u. injection of PGF (PGF bolus group) than after the beginning of an i.u. infusion of PGF to simulate a natural PGFM pulse (PGF infusion group). After the peak of the transient increase, progesterone decreased in both groups until 1 or 2 h after the beginning of the treatment and then rebounded. The percentage of the area of the CL with colour-Doppler signals of blood flow increased concomitantly with the immediate posttreatment progesterone increase in the PGF bolus group, but did not change with the progesterone increase in the PGF infusion group.
Luteal blood flow and progesterone production A continuing elevation in blood flow in the PGF bolus group and a slight increase in the PGF infusion group occurred during the progesterone decrease before the progesterone rebound. Blood flow decreased during the descending arm of the progesterone rebound in both groups. Cortisol and prolactin increased immediately in the PGF bolus group but not in the PGF infusion group, indicating that interpretations on the nature of the luteolytic mechanism are dubious when based on a single pharmacologic luteolytic dose of PGF.
Materials and Methods

Heifers and treatments
The heifers were Holsteins and were 18-24 months of age. The management of heifers, including housing and feeding, and the ultrasonographic monitoring for ovulation detection have been described (Shrestha et al. 2010) . Heifers were selected with docile temperament and no apparent abnormalities of the reproductive tract as determined by ultrasound examinations (Ginther 1998) . Heifers with multiple CL were not used. The experiment was done during February to April in the northern hemisphere. Animals were handled according to the United States Department of Agriculture Guide for Care and Use of Agricultural Animals in Agricultural Research.
Dinoprost tromethamine (Lutalyse; Pfizer Animal Health, New York City, NY, USA) was used for the PGF treatment. According to the manufacturer, the product contains the naturally occurring PGF (dinoprost) as the tromethamine salt. Heifers were randomized into four groups (nZ9 heifers/group): saline infusion (6 ml of PBS infused i.u. during 2 h), PGF infusion (a total of 0.5 mg of PGF in 6 ml of PBS infused i.u. during 2 h), saline bolus (0.8 ml bolus of PBS injected i.u.) and PGF bolus (4 mg of PGF (0.8 ml Lutalyse) injected i.u). The 2-h i.u. infusion of 0.5 mg PGF was used to approximately simulate a natural PGFM pulse as reported previously (Ginther et al. 2009a) . The bolus i.u. injection of 4 mg PGF was used as a single dose of PGF that stimulates an initial progesterone increase before a complete decrease (Shrestha et al. 2010) . The PGF was infused during 2 h or injected as a bolus into the cranial portion of the uterine horn ipsilateral to the CL through an i.u. tubing. The ipsilateral i.u. route of PGF administration was used, owing to the natural unilateral delivery of PGF between a uterine horn and the CL in the adjacent ovary in cattle (Ginther et al. 1967 (Ginther et al. , 2009a . The procedures for placement of tubing for infusion of the PGF and for the bolus i.u. injection have been described (Shrestha et al. 2010) .
The day of treatment as well as the treatment product, doses and route were patterned after previously reported studies (Ginther et al. 2009a , 2009b , Shrestha et al. 2010 . The experiment began between 0900 and 1100 h 9 days after ovulation. The ultrasonographer was unaware of the two treatments given to heifers within the two infusion groups as well as within the two bolus groups. The time of the bolus injection or the beginning of infusion was designated Minute 0 to study the immediate transient progesterone increase and as Hour 0 to study the rebound. Placement of the tubing into the uterine horn with external fixation in the infusion groups began 15-20 min before the beginning of i.u. infusion (Minute 0). In the bolus groups, placement of the tubing required only a few minutes and external fixation was not used; the injection of PGF (Minute 0) was done immediately after tube placement. The study ended at Hour 6, except for determining the length of the interovulatory interval.
Ultrasound scanning and luteal blood flow estimation
A duplex B-mode (grey scale) and pulsed-wave colour-Doppler ultrasound instrument (Aloka SSD 3500; Aloka American, Wallingford, CT, USA) equipped with a linear-array 7.5-MHz transducer was used for transrectal scanning of the ovaries. B-mode was used for daily scanning of the ovaries to determine the day of ovulation and for placement and monitoring the location of the tip of the i.u. tubing in the cranial portion of the uterine horn. Power-Doppler mode was used for luteal blood flow estimates. All Doppler scans were performed at a preset setting for colour gain and velocity (R6 cm/s) as described (Ginther 2007 , Ginther et al. 2007b . Luteal blood flow or the percentage of CL area with blood flow colour displays was estimated from the real-time sequential two-dimensional planes of the entire CL. The colour flow signals at the periphery of the CL and within the CL were included in the percentage estimates; previous study has shown major involvement of the peripheral vessels during luteolysis (Shirasuna et al. 2008) . The subjective estimation of the percentage of CL area with blood flow signals as an end point in cattle has been described in detail and validated with independent operators and objectively by using coloured pixels in still images (Ginther 2007 , Ginther et al. 2007b , Araujo & Ginther 2009 ).
An estimation of luteal blood flow was done, and a blood sample was taken at Minutes 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 25, 30, 45 and 60 from all 36 heifers to characterize the potential immediate transient changes in progesterone and luteal blood flow. Estimation of luteal blood flow and blood sampling were continued in 20 (nZ5/group) heifers randomly selected from the group of 36 at Hours 2, 2. 25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 5 and 6 . Hours 0 and 1 were the same as Minutes 0 and 60, and the examinations at Hours 0 and 1 to 6 were done to characterize the potential rebound in progesterone and the associated changes in luteal blood flow. The increased frequency of examinations at Hours 2-4 was included to improve the determination of the time of the peak of the progesterone rebound and the associated changes in blood flow.
Blood sampling and hormone assays
Frequent blood sampling was facilitated by an indwelling catheter in a jugular vein. For catheter insertion, the heifers were sedated with 14 mg/heifer (i.m.) of xylazine hydrochloride (AnaSed Injection, Akorn Inc., Decatur, IL, USA). Xylazine sedation reportedly (Araujo & Ginther 2009) produces haemodynamic effects when assessed in a major artery (internal iliac), but does not affect local vascular perfusion in the ovaries. The sedative was used only for catheter placement.
The blood samples were collected into heparinized tubes and immediately placed in an ice-water bath and centrifuged (2000 g for 10 min). The plasma was decanted and stored at K20 8C until assayed. All plasma samples from the 36 heifers were assayed for progesterone, LH, FSH and prolactin. Plasma samples collected during Minutes 0, 2, 6, 10, 14, 20, 30 and 60 from five randomly selected heifers per group were assayed for PGFM, oestradiol-17b and cortisol. Plasma progesterone concentrations were assayed with a solid-phase RIA kit containing antibody-coated tubes and 125 I-labelled progesterone (Coat-A-Count Progesterone, Diagnostic Products Corporation, Los Angeles, CA, USA). The procedure has been validated and described in detail for bovine plasma in our laboratory (Ginther et al. 2007b) . The intra-and interassay coefficients of variation (CV) and sensitivity were 6.1%, 6.3% and 0.01 ng/ml respectively. Plasma LH and FSH concentrations were assayed by RIAs as described for cattle (Bolt et al. 1990 ) with validations and modifications as reported by our laboratory for LH (Ginther et al. 1999) and FSH (Adams et al. 1992) and with further recent modifications as reported for both assays (Palhao et al. 2009 ). The intra-and interassay CV and sensitivity respectively were 9.2%, 10.5% and 0.03 ng/ml for LH and 6.5%, 4.8% and 0.07 ng/ml for FSH. Plasma concentrations of oestradiol were measured as described and validated in our laboratory (Siddiqui et al. 2009 ) using a commercially available RIA kit (Double Antibody Oestradiol: Diagnostic Products Corporation). The intraassay CV and sensitivity were 14.9% and 0.1 pg/ml respectively.
Plasma prolactin concentrations were determined by a homologous double-antibody RIA as described (Benoit et al. 2009 ) with modifications. Briefly, highly purified bovine prolactin (AFP-6432B) and primary antibody (rabbit antibovine prolactin antibody AFP-753180) were obtained from Dr A F Parlow (National Hormone and Peptide Program, Torrance, CA, USA). Secondary antibody (sheep anti-rabbit IgG; H & L, Cat. No. PEL-07418) and normal rabbit serum (TBS-RS 6349) were obtained from the Biotech Source Inc., Franklin, MA, USA. Radioiodination of prolactin was done by the iodogen method as described (Matteri et al. 1987) . Assay buffer (0.05 M sodium phosphate buffer, pH 7.4) contained 0.9% NaCl, 1.0% BSA (RIA grade, Cat. No. A 7888; Sigma-Aldrich Inc.) and 0.02% sodium azide. The buffer was used for making prolactin standards and dilution of primary and secondary antisera and the radiolabelled trace. For the assay, 100 ml of standards (100-0.78 ng/ml) or plasma samples were pipetted into glass assay tubes, followed immediately by the addition of 200 ml of primary antibody (diluted 1:100 000 in assay buffer containing 0.33% normal rabbit serum) and 100 ml of iodinated ( 125 I) prolactin trace (25 000 c.p.m). The mixture was incubated at room temperature for 48 h. Then, 200 ml of secondary antibody (diluted 1:30 in assay buffer) and 0.5 ml of polyethylene glycol (6% in distilled water; Cat. No. P2139; Sigma-Aldrich Inc.) were added. The tubes were vortexed and incubated at 4 8C for 24 h, followed by centrifugation at 1700 g for 30 min at 4 8C. The supernatant was decanted, and the tubes were allowed to dry by keeping them inverted for at least 1 h and then counted in a gamma counter. Serial volumes of a pool of bovine plasma (50-300 ml) and serial dilutions of plasma spiked with prolactin (50 ng/ml) were also run in the assay, and this resulted in a displacement curve that was similar to the standard curve. The intraassay CV and sensitivity were 6.6% and 0.42 ng/ml respectively. Plasma cortisol concentrations were determined using a solid-phase RIA kit containing antibody-coated tubes and 125 I-labelled cortisol (Coat-A-Count Cortisol; Diagnostic Products Corporation) with modifications. The kit-supplied standards (10-500 ng/ml; 25 ml) and plasma samples (75 ml) were pipetted into antibody-coated tubes. Cortisol tracer (1 ml) was added to each tube, and the tubes were vortexed and incubated for 45 min at 37 8C in a water bath. The tubes were decanted, drained and counted for 1 min in a gamma counter. Serial volumes of a pool of bovine plasma (50-100 ml) were processed as for the experimental samples, and this resulted in a displacement curve that was similar to the standard curve. The intraassay CV and the sensitivity were 4.7% and 1.0 ng/ml respectively.
The plasma samples were assayed for PGFM by an enzyme immunoassay that was developed in our laboratory for measuring the concentrations of PGFM in bovine plasma. The PGFM (catalogue # D4143; Sigma Chemical Co.) was used to prepare standards and the PGFM-HRP conjugate. The secondary antibody (goat anti-rabbit) was purchased (catalogue # ab6702; Abcam Inc., Cambridge, MA, USA), and the primary antibody (rabbit anti-PGFM; J57) was a gift from Dr W W Thatcher of the University of Florida. The PGFM-HRP conjugate was prepared according to the method described (Hayashi & Yamamoto 1982) with modifications in our laboratory. Standards (10 000 to 19.5 pg/ml) of PGFM were prepared in PG-free (banamine-treated) bovine plasma (Ginther et al. 2007b) . Aliquots of 250 ml of standards and unknown samples were transferred to glass extraction tubes, and the pH was adjusted to 3.0 with dilute hydrochloric acid. All the tubes were extracted with 2 ml of diethyl ether, and the extracts were allowed to dry. The dried extract was dissolved in 250 ml of ELISA buffer, vortexed for 2 min and incubated for 1 h at room temperature. The redissolved extract was run in a competitive ELISA, and the colour development was measured by taking the optical density at a dual wavelength of 450 and 600 nm. Serial volumes of a pool of bovine plasma (100 to 7.5 ml) containing high PGFM from PGF-treated heifers were processed as for the experimental samples, and this resulted in a displacement curve that was similar to the standard curve. The intra-and interassay CV and sensitivity were 11.4%, 14.2% and 5.3 pg/ml respectively.
Statistical analyses
Data that were not normally distributed based on the ShapiroWilk test were transformed to natural logarithms or ranks. Significant (P!0.01) outliers based on the Dixon test (Kanji 1993) were removed from the analyses and were indicated only for prolactin. The means for prolactin were different among groups at Minute 0, and data for each heifer and minute were converted to percentage change from Minute or Hour 0 for statistical analyses. This was done to minimize the effects of autocorrelation within heifers. Data for each end point were analyzed for main effects of group and minute/hour and the group-by-minute/hour interaction. The SAS MIXED procedure (Version 9.2; SAS Institute, Inc., Cary, NC, USA) was used for statistical analyses with a REPEATED statement to minimize autocorrelation between sequential measurements and with spatial power to account for uneven intervals between samples. When an interaction was obtained, group and minute/hour effects and their interaction were further analyzed. Student's paired t-tests were used between two minutes/hours within a group to locate significant increases and decreases. Duncan's multiple-range test was used to locate differences among groups within a minute/hour using percentage change from Minute or Hour 0. A probability of P%0.05 indicated that a difference was significant, and a probability of PO0.05 to P%0.1 indicated that significance was approached. Data are presented as the meanGS.E.M.
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